Avid bioservices reports q3 loss per share $0.06

Avid bioservices reports financial results for third quarter fiscal 2020 and recent developments.q3 loss per share $0.06.q3 revenue $13.6 million versus refinitiv ibes estimate of $15.4 million.q3 earnings per share estimate $-0.04 -- refinitiv ibes data.adjusting fiscal 2020 projected revenue to $55 million to $59 million.temporary production interruption resulted in lower revenue and profits for q3.anticipate that production interruption impact will be contained to fiscal 2020.
CDMO Ratings Summary
CDMO Quant Ranking